Hardie R
Br J Hosp Med. 1985 Jan;33(1):45-6, 48-9.
Levodopa is widely regarded as the treatment of choice in Parkinson's disease although complications gradually emerge during long-term therapy. The addition of adjuvants may be worthwhile, but it must be recognized that drug therapy offers incomplete and diminished symptom relief.
